Back to Ingredient Dictionary
Common Name(s): P-butylresorcinol,rucinol
CAS Number: 18979-61-8
DESCRIPTION
What It Does: Provides exceptional brightening through the most potent tyrosinase inhibition of any commonly used cosmetic brightening agent.
Why It's Used: The most potent tyrosinase inhibitor available in cosmetics – exceptional for refractory hyperpigmentation and melasma where standard brighteners provide insufficient efficacy.
How It Works: Resorcinol backbone competitively inhibits both tyrosine hydroxylase (reaction 1) and dopa oxidase (reaction 2) activities of tyrosinase. n-butyl chain provides superior membrane affinity for enhanced delivery to melanosomes.
Typically Found In: High-potency brightening serums,melasma treatments,stubborn hyperpigmentation products
TECHNICAL DETAILS
Primary Category: Active ingredient – resorcinol tyrosinase inhibitor
Secondary Functions: Dual tyrosinase reaction inhibition,potent brightening
Application Areas:
Facial Skincare
Body Care
Hair Care
Beard Care
Color Cosmetics (Makeup)
Dietary/Oral Supplements
Typical Concentration Range: 0.1%–1%
SOURCING & ETHICS
Vegan Status: Yes – synthetic
Halal Status: Yes
Source Notes: Synthetic or plant-derived.
SKIN COMPATIBILITY
Irritancy Rating: 2/5 – low to moderate
Comedogenicity Rating: 0/5 – non-comedogenic
Sensitivity Concerns: Use with spf; introduce gradually. photosensitizing.
Safe for Sensitive Skin: Yes
SAFETY & COMPATIBILITY
Safety Profile: Excellent safety profile. use with spf for maximum efficacy. ewg score: 1.
Works Well With: Niacinamide,vitamin c,alpha-arbutin,tranexamic acid,spf
Avoid Combining With: No significant incompatibilities
SCIENTIFIC NOTE
4-butylresorcinol's inhibition of both tyrosinase catalytic reactions (tyrosine→dopa and dopa→dopaquinoneoxidase) is unique among common brighteners. most tyrosinase inhibitors only block the first reaction (tyrosine→dopa). blocking both steps provides more complete melanin biosynthesis inhibition.
Last Verified: ##########
Primary Sources: Cosing database,choi et al. 4-butylresorcinol study,sccs opinion on butylresorcinol